Novartis AG (NVS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Novartis AG, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$156.08
−0.50% today
Market cap
$299.3B
Overall quality
—
Kronos AI 30-day
−3.9%
0 of 8 simulated paths end higher
Novartis AG (NVS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $299.3B. It trades at $156.08, down 0.50% today. 4 analysts' average target of $159.67 implies +2.3% from today's price. Kronos AI's 30-day forecast is −3.9% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $159.67 |
| Low – high | $136.00 – $180.00 |
| Analysts | 4 |
| Upside to average | +2.3% |
Kronos AI 30-day forecast
| Expected close | $150.68 (−3.9%) |
| Likely range | −6.0% … −1.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.